DBV TECHNOLOGIES S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.65 USD | +3.17% |
|
+10.26% | -31.78% |
| May. 20 | European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading | MT |
| May. 20 | DBV Technologies: towards a change in ADS ratio | CF |
ETFs positioned on DBV Technologies S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.03% | 0 M€ | 0.00% | - | |
| 0.02% | 0 M€ | 0.00% | - |
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Sector
Pharmaceuticals
Calendar
2024-07-28
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.32
EUR
Average target price
4.733
EUR
Spread / Average Target
+258.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.89% | 78.65B | |
| +9.32% | 8.94B | |
| -10.76% | 5.16B | |
| +54.31% | 4.85B | |
| +11.19% | 4.19B | |
| -22.37% | 2.32B | |
| +11.31% | 2.29B | |
| -30.09% | 2.19B | |
| +20.63% | 2.19B |
- Stock Market
- Equities
- DBV Stock
- DBVT Stock
- Funds and ETFs DBV Technologies S.A.
